Adicet Bio, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Adicet Bio, Inc. (ACET) reported Increase (Decrease) in Prepaid Expense and Other Assets of $178.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-05
- Adicet Bio, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $93.00K.
- Adicet Bio, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $85.00K.
- Adicet Bio, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$1.19M.
- Adicet Bio, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $619.00K.
- Adicet Bio, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$1.68M, a 232.26% decline from fiscal 2024.
- Adicet Bio, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $1.27M.
- Adicet Bio, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$926.00K.
- Adicet Bio, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$1.34M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $93.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $178.00K 10-Q · filed 2026-08-05 | -$1.01M derived: sum of 3 quarters · filed 2026-08-05 | -$394.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $85.00K 10-Q · filed 2026-05-13 | -$1.11M derived: sum of 2 quarters · filed 2026-05-13 | -$487.00K derived: sum of 3 quarters · filed 2026-05-13 | -$834.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | -$1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$572.00K derived: sum of 2 quarters · filed 2026-03-12 | -$919.00K derived: sum of 3 quarters · filed 2026-08-05 | -$1.68M 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | $619.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $272.00K derived: sum of 2 quarters · filed 2026-08-05 | -$490.00K 10-Q · filed 2025-11-05 | -$909.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | -$347.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.11M 10-Q · filed 2026-08-05 | -$1.53M derived: sum of 3 quarters · filed 2026-08-05 | -$1.56M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | -$762.00K 10-Q · filed 2026-05-13 | -$1.18M derived: sum of 2 quarters · filed 2026-05-13 | -$1.21M derived: sum of 3 quarters · filed 2026-05-13 | $309.00K derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$419.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$452.00K derived: sum of 2 quarters · filed 2026-03-12 | $1.07M derived: sum of 3 quarters · filed 2026-03-12 | $1.27M 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | -$33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.49M derived: sum of 2 quarters · filed 2025-11-05 | $1.69M 10-Q · filed 2025-11-05 | $1.52M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.72M 10-Q · filed 2025-08-07 | $1.55M derived: sum of 3 quarters · filed 2025-08-07 | $983.00K derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $200.00K 10-Q · filed 2025-05-06 | $30.00K derived: sum of 2 quarters · filed 2025-05-06 | -$540.00K derived: sum of 3 quarters · filed 2025-05-06 | -$512.00K derived: sum of 4 quarters · filed 2025-05-06 | ||||
| 2023-12-31 | -$170.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$740.00K derived: sum of 2 quarters · filed 2025-03-06 | -$712.00K derived: sum of 3 quarters · filed 2025-03-06 | -$926.00K 10-K · filed 2025-03-06 | ||||
| 2023-09-30 | -$570.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$542.00K derived: sum of 2 quarters · filed 2024-11-06 | -$756.00K 10-Q · filed 2024-11-06 | -$403.00K derived: sum of 4 quarters · filed 2024-11-06 | ||||
| 2023-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$186.00K 10-Q · filed 2024-08-13 | $167.00K derived: sum of 3 quarters · filed 2024-08-13 | -$249.00K derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | -$214.00K 10-Q · filed 2024-05-14 | $139.00K derived: sum of 2 quarters · filed 2024-05-14 | -$277.00K derived: sum of 3 quarters · filed 2024-05-14 | -$480.00K derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $353.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$63.00K derived: sum of 2 quarters · filed 2024-03-19 | -$266.00K derived: sum of 3 quarters · filed 2024-03-19 | -$1.34M 10-K · filed 2024-03-19 | ||||
| 2022-09-30 | -$416.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$619.00K derived: sum of 2 quarters · filed 2023-11-08 | -$1.70M 10-Q · filed 2023-11-08 | -$3.79M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | -$203.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.28M 10-Q · filed 2023-08-09 | -$3.38M derived: sum of 3 quarters · filed 2023-08-09 | -$4.15M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | -$1.08M 10-Q · filed 2023-05-09 | -$3.17M derived: sum of 2 quarters · filed 2023-05-09 | -$3.95M derived: sum of 3 quarters · filed 2023-05-09 | -$2.67M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | -$2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$2.87M derived: sum of 2 quarters · filed 2023-03-15 | -$1.60M derived: sum of 3 quarters · filed 2023-03-15 | -$1.63M 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | -$778.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $498.00K derived: sum of 2 quarters · filed 2022-11-08 | $462.00K 10-Q · filed 2022-11-08 | -$1.30M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $1.24M 10-Q · filed 2022-08-10 | -$527.00K derived: sum of 3 quarters · filed 2022-08-10 | $1.58M derived: sum of 4 quarters · filed 2022-08-10 | ||||
| 2021-03-31 | -$36.00K 10-Q · filed 2022-05-12 | -$1.80M derived: sum of 2 quarters · filed 2022-05-12 | $300.00K derived: sum of 3 quarters · filed 2022-05-12 | $175.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $336.00K derived: sum of 2 quarters · filed 2022-03-15 | $211.00K derived: sum of 3 quarters · filed 2022-03-15 | $3.23M 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | $2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.98M derived: sum of 2 quarters · filed 2021-11-10 | $5.00M 10-Q · filed 2021-11-10 | $4.43M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | -$125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $2.90M 10-Q · filed 2021-08-12 | $1.08M 10-Q · filed 2020-07-30 | $2.33M derived: sum of 3 quarters · filed 2021-08-12 | -$294.00K derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | $3.02M 10-Q · filed 2021-05-17 | -$542.00K 10-Q · filed 2020-05-07 | $2.45M derived: sum of 2 quarters · filed 2021-05-17 | -$169.00K derived: sum of 3 quarters · filed 2021-05-17 | $1.54M derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | -$568.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$3.19M derived: sum of 2 quarters · filed 2021-03-12 | -$1.49M derived: sum of 3 quarters · filed 2021-03-12 | -$1.41M 10-K · filed 2021-03-12 | $274.00K 10-K · filed 2020-03-12 | |||
| 2019-09-30 | -$2.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$918.00K derived: sum of 2 quarters · filed 2020-11-05 | -$837.00K 10-Q · filed 2020-11-05 | $2.51M 10-Q · filed 2019-11-05 | $1.22M derived: sum of 4 quarters · filed 2021-03-12 | |||
| 2019-06-30 | $1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $1.79M 10-Q · filed 2020-07-30 | $3.84M derived: sum of 3 quarters · filed 2021-03-12 | $3.04M derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2019-03-31 | $81.00K 10-Q · filed 2020-05-07 | $2.14M derived: sum of 2 quarters · filed 2021-03-12 | $1.33M derived: sum of 3 quarters · filed 2021-03-12 | $2.64M derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2018-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $1.25M derived: sum of 2 quarters · filed 2021-03-12 | $2.56M derived: sum of 3 quarters · filed 2021-03-12 | $2.83M 10-K · filed 2021-03-12 | $630.00K 10-K · filed 2019-03-18 | |||
| 2018-09-30 | -$804.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $505.00K derived: sum of 2 quarters · filed 2019-11-05 | $769.00K 10-Q · filed 2019-11-05 | $1.43M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $1.57M 10-Q · filed 2019-08-14 | $2.23M derived: sum of 3 quarters · filed 2020-03-12 | $1.92M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | $264.00K 10-Q · filed 2019-05-15 | $926.00K derived: sum of 2 quarters · filed 2020-03-12 | $608.00K derived: sum of 3 quarters · filed 2020-03-12 | $911.00K derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | $662.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $344.00K derived: sum of 2 quarters · filed 2020-03-12 | $647.00K derived: sum of 3 quarters · filed 2020-03-12 | $876.00K 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | -$318.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$15.00K derived: sum of 2 quarters · filed 2018-11-13 | $214.00K 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | $303.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $532.00K 10-Q · filed 2018-08-09 | ||||||
| 2017-03-31 | $229.00K 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |